Cardiovascular Risk and Treatment Outcomes in Severe Hypercholesterolemia: A Nationwide Cohort Study

Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia

(2020) et al.   JAMA Cardiology

Familial hypercholesterolaemia: history, diagnosis, screening, management and challenges

(2020) Erik Berg Schmidt et al.   HEART

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol

(2019) Scott M. Grundy et al.   CIRCULATION

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   ATHEROSCLEROSIS

Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register

(2018) S.E. Humphries et al.   ATHEROSCLEROSIS

Relationship of Familial Hypercholesterolemia and High LDL Cholesterol to Ischemic Stroke: The Copenhagen General Population Study

(2018) Sabina Beheshti et al.   CIRCULATION

Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia

(2018) Liv J Mundal et al.   HEART

Familial hypercholesterolemia and atherosclerotic cardiovascular mortality among Korean adults with low levels of serum cholesterol

(2018) Keum Ji Jung et al.   ATHEROSCLEROSIS

Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia

(2016) Leopoldo Perez de Isla et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia

(2016) Amit V. Khera et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Statins in Familial Hypercholesterolemia

(2016) Joost Besseling et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel

(2016) Raul D Santos et al.   Lancet Diabetes & Endocrinology

Clinical features of familial hypercholesterolemia in Korea: Predictors of pathogenic mutations and coronary artery disease – A study supported by the Korean Society of Lipidology and Atherosclerosis

(2015) Dong Geum Shin et al.   ATHEROSCLEROSIS

Background and Data Configuration Process of a Nationwide Population-Based Study Using the Korean National Health Insurance System

(2014) Sun Ok Song et al.   Diabetes & Metabolism Journal

Diagnosis and treatment of familial hypercholesterolaemia

(2013) G. Kees Hovingh et al.   EUROPEAN HEART JOURNAL

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

(2013) B. G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication

(2012) Marianne Benn et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands

(2009) A.H. Pijlman et al.   ATHEROSCLEROSIS